A COST-EFFECTIVENESS ANALYSIS OF THE CNICPOLYPILL STRATEGY, COMPARED TO USUAL CARE, IN SECONDARY CARDIOVASCULAR PREVENTION FROM A SPANISH PERSPECTIVE USING DATA FROM THE SECURE TRIAL

被引：0
|
作者：
Hopmans, M. [1 ]
Castellano Vazquez, J. M. [2 ]
Gaziano, T. [3 ]
Dymond, A. [4 ]
Looby, A. [4 ]
Mealing, S. [4 ]
Hansell, N. [4 ]
Eastwood, I
Montpart, F. [1 ]
Owen, R. [5 ]
Pocock, S. [5 ]
Cordero, A. [6 ,7 ]
Gonzalez-Juanatey, J. R. [8 ]
Fernandez, A. [9 ]
Merkely, B. [10 ]
Linhart, A. [11 ]
Schiele, F. [12 ]
Doehner, W. [13 ]
Roncaglioni, M. C. [14 ]
Ponikowski, P. [15 ]
Fuster, V [2 ]
机构：
[1] Ferrer Int, Barcelona, Spain
[2] Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain
[3] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[4] York Hlth Econ Consortium, York, N Yorkshire, England
[5] London Sch Hyg & Trop Med London, London, England
[6] Hosp Univ San Juan, Alicante, Spain
[7] Hosp Univ San Juan, Alicante, Spain
[8] Hosp Clin Univ Santiago De Compostela, Santiago De Compostela, Spain
[9] Hosp Univ Clin San Carlos, Madrid, Spain
[10] Varosmajori Sziv Ergyogyaszati Klin, Budapest, Hungary
[11] Vseobecna Fak Nemocn & Praze, Prague, Czech Republic
[12] Reg Univ Hosp Jean Minjoz, Besancon, France
[13] Charite Univ Med Berlin, Berlin, Germany
[14] IRCCS Ist Ric Farmacol Mario Negri, Milan, Italy
[15] Wroclaw Med Univ, Wroclaw, Poland
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE615
引用
下载
收藏
页码：S171 / S171
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK
    Becerra, Virginia
    Gracia, Alfredo
    Desai, Kamal
    Abogunrin, Seye
    Brand, Sarah
    Chapman, Ruth
    Garcia Alonso, Fernando
    Fuster, Valentin
    Sanz, Gines
    BMJ OPEN, 2015, 5 (05):
  • [22] Cost-Effectiveness of the CNIC-Polypill Strategy Compared With Separate Monocomponents in Secondary Prevention of Cardiovascular and Cerebrovascular Disease in Portugal: The MERCURY Study
    Aguiar, Carlos
    Araujo, Francisco
    Rubio-Mercade, Gabriel
    Carcedo, David
    Paz, Silvia
    Castellano, Jose Maria
    Fuster, Valentin
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2022, 9 (02): : 134 - 146
  • [23] Cost-effectiveness of early rhythm control vs. usual care in atrial fibrillation care: an analysis based on data from the EAST-AFNET 4 trial
    Gottschalk, Sophie
    Kany, Shinwan
    Koenig, Hans-Helmut
    Crijns, Harry J. G. M.
    Vardas, Panos
    Camm, A. John
    Wegscheider, Karl
    Metzner, Andreas
    Rillig, Andreas
    Kirchhof, Paulus
    Dams, Judith
    EUROPACE, 2023, 25 (05):
  • [24] COST ANALYSIS, COST-EFFECTIVENESS, AND COST-UTILITY OF HYPERTENSION AND HYPERLIPIDEMIA COLLABORATIVE MANAGEMENT BETWEEN PHARMACIES AND PRIMARY CARE IN PORTUGAL ALONGSIDE A TRIAL COMPARED WITH USUAL CARE (USFARMACIA®)
    Costa, S.
    Guerreiro, J.
    Teixeira, I
    Helling, D. K.
    Pereira, J.
    Mateus, C.
    VALUE IN HEALTH, 2022, 25 (12) : S161 - S162
  • [25] Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease
    Jowett, Sue
    Barton, Pelham
    Roalfe, Andrea
    Fletcher, Kate
    Hobbs, F. D. Richard
    McManus, Richard J.
    Mant, Jonathan
    PLOS ONE, 2017, 12 (09):
  • [26] Cost-effectiveness of group medical visits and microfinance interventions versus usual care to manage hypertension in Kenya: a secondary modelling analysis of data from the Bridging Income Generation with Group Integrated Care (BIGPIC) trial
    Chay, Junxing
    Su, Rebecca J.
    Kamano, Jemima H.
    Andama, Benjamin
    Bloomfield, Gerald S.
    Delong, Allison K.
    Horowitz, Carol R.
    Menya, Diana
    Mugo, Richard
    Orango, Vitalis
    Pastakia, Sonak D.
    Wanyonyi, Cleophas
    Vedanthan, Rajesh
    Finkelstein, Eric A.
    LANCET GLOBAL HEALTH, 2024, 12 (08): : e1331 - e1342
  • [27] LONG TERM COST-EFFECTIVENESS ANALYSIS OF TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROMES FROM A TURKISH HEALTH CARE PERSPECTIVE BASED ON DATA FROM THE PLATO TRIAL
    Abaci, A.
    Bozkurt, E.
    Mellstrom, C.
    Caglayan, B.
    VALUE IN HEALTH, 2012, 15 (07) : A370 - A370
  • [28] Cost-effectiveness of counselling, graded-exercise and usual care for chronic fatigue: evidence from a randomised trial in primary care
    Sabes-Figuera, Ramon
    McCrone, Paul
    Hurley, Mike
    King, Michael
    Donaldson, Ana Nora
    Ridsdale, Leone
    BMC HEALTH SERVICES RESEARCH, 2012, 12
  • [29] Cost-effectiveness of counselling, graded-exercise and usual care for chronic fatigue: evidence from a randomised trial in primary care
    Ramon Sabes-Figuera
    Paul McCrone
    Mike Hurley
    Michael King
    Ana Nora Donaldson
    Leone Ridsdale
    BMC Health Services Research, 12
  • [30] Cost-Effectiveness of Antihypertensive Deprescribing in Primary Care: a Markov Modelling Study Using Data From the OPTiMISE Trial
    Jowett, Sue
    Kodabuckus, Shahela
    Ford, Gary A.
    Hobbs, F. D. Richard
    Lown, Mark
    Mant, Jonathan
    Payne, Rupert
    McManus, Richard J.
    Sheppard, James P.
    HYPERTENSION, 2022, 79 (05) : 1122 - 1131
12345